Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis

NCT02770040 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

138

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Infliximab

Sponsor

Austin Health

Collaborators

[object Object]